S Ritland

2.3k total citations
74 papers, 1.8k citations indexed

About

S Ritland is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, S Ritland has authored 74 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 24 papers in Surgery and 24 papers in Hepatology. Recurrent topics in S Ritland's work include Liver Disease Diagnosis and Treatment (29 papers), Cholesterol and Lipid Metabolism (10 papers) and Liver Diseases and Immunity (10 papers). S Ritland is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Cholesterol and Lipid Metabolism (10 papers) and Liver Diseases and Immunity (10 papers). S Ritland collaborates with scholars based in Norway, United Kingdom and Sweden. S Ritland's co-authors include E Gjone, O. Fausa, E. Schrumpf, K. Elgjo, Kjell B. Hellum, J. P. Blomhoff, F. Kolmannskog, Olav Dalgård, N Raknerud and Kjell Skaug and has published in prestigious journals such as The Lancet, Hepatology and American Journal of Epidemiology.

In The Last Decade

S Ritland

73 papers receiving 1.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
S Ritland 970 898 468 205 160 74 1.8k
Steven P. Mistilis 540 0.6× 533 0.6× 325 0.7× 156 0.8× 93 0.6× 44 1.3k
J P Benhamou 701 0.7× 491 0.5× 477 1.0× 90 0.4× 76 0.5× 61 1.4k
Edmondo Falleti 1.1k 1.1× 1.5k 1.7× 327 0.7× 251 1.2× 130 0.8× 94 3.0k
Anastasios A. Mihas 992 1.0× 1.1k 1.2× 847 1.8× 367 1.8× 44 0.3× 60 2.1k
Charles Trey 1.1k 1.1× 802 0.9× 705 1.5× 227 1.1× 58 0.4× 54 2.0k
Graeme J.M. Alexander 1.5k 1.6× 1.2k 1.3× 673 1.4× 80 0.4× 116 0.7× 27 2.3k
William P. Baldus 1.1k 1.2× 878 1.0× 460 1.0× 214 1.0× 42 0.3× 32 2.1k
Jean‐Claude Chaput 1.2k 1.2× 1.9k 2.1× 531 1.1× 144 0.7× 44 0.3× 47 2.6k
Kristian Bjøro 1.6k 1.7× 1.9k 2.2× 592 1.3× 274 1.3× 144 0.9× 79 3.0k
D.B. McGill 564 0.6× 740 0.8× 383 0.8× 134 0.7× 195 1.2× 17 1.4k

Countries citing papers authored by S Ritland

Since Specialization
Citations

This map shows the geographic impact of S Ritland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Ritland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Ritland more than expected).

Fields of papers citing papers by S Ritland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Ritland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Ritland. The network helps show where S Ritland may publish in the future.

Co-authorship network of co-authors of S Ritland

This figure shows the co-authorship network connecting the top 25 collaborators of S Ritland. A scholar is included among the top collaborators of S Ritland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Ritland. S Ritland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalgård, Olav, Helmer Ring‐Larsen, Einar S. Björnsson, et al.. (2007). Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response. Hepatology. 47(1). 35–42. 135 indexed citations
2.
Ritland, S, et al.. (2004). Feil og mangelfull kurveføring – en potensiell kilde til feilmedisinering. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
3.
Dalgård, Olav, Kristian Bjøro, Kjell B. Hellum, et al.. (2004). Treatment With Pegylated Interferon and Ribavarin in Hcv Infection With Genotype 2 Or 3 for 14 Weeks: A Pilot Study. Hepatology. 40(6). 1260–1265. 240 indexed citations
4.
Bjøro, Kristian, H. Bell, B Myrvang, et al.. (2002). Effect of Interferon-α Induction Therapy on Genotype 2b/3a and Low Viral Load Hepatitis C Virus Infection: A Randomized Multicentre Study. Scandinavian Journal of Gastroenterology. 37(3). 344–349. 12 indexed citations
5.
Bell, Helge, Kjell B. Hellum, Stig Harthug, et al.. (1997). Genotype, Viral Load and Age as Independent Predictors of Treatment Outcome of Interferon-α2a Treatment in Patients with Chronic Hepatitis C. Scandinavian Journal of Infectious Diseases. 29(1). 17–22. 46 indexed citations
6.
Bell, Helge, Kjell B. Hellum, Stig Harthug, et al.. (1996). Prevalence of Hepatitis C Genotypes among Patients with Chronic Hepatitis C in Norway. Scandinavian Journal of Infectious Diseases. 28(4). 357–359. 15 indexed citations
7.
Ritland, S, et al.. (1996). Acute Pancreatitis in Buskerud County, Norway Incidence and Etiology. Scandinavian Journal of Gastroenterology. 31(4). 411–414. 50 indexed citations
8.
Andersen, Geir Øystein & S Ritland. (1995). Life Threatening Intoxication with Sodium Valproate. Journal of Toxicology Clinical Toxicology. 33(3). 279–284. 54 indexed citations
9.
Ritland, S, et al.. (1993). Clostridium perfringens septicemia with massive hemolysis. Infection. 21(1). 54–56. 38 indexed citations
10.
Ritland, S, et al.. (1992). Gastrointestinal Problems Related to Endurance Event Training. Sports Medicine. 14(3). 157–163. 15 indexed citations
11.
Andersen, Bjørg Marit, Tom Bergan, Johan N. Bruun, et al.. (1992). Ciprofloxacin versus a Tobramycin/Cefuroxime Combination in the Treatment of Serious Systemic Infections: A Prospective, Randomized and Controlled Study of Efficacy and Safety. Scandinavian Journal of Infectious Diseases. 24(5). 637–646. 15 indexed citations
12.
Ritland, S, et al.. (1992). Hilar Lymphadenopathy Associated with Chlamydia pneumoniae Infection. Scandinavian Journal of Infectious Diseases. 24(3). 387–389. 4 indexed citations
13.
Ritland, S. (1988). Exercise and Liver Disease. Sports Medicine. 6(2). 121–126. 9 indexed citations
14.
Ritland, S & Jan Aaseth. (1987). Trace elements and the liver. Journal of Hepatology. 5(1). 118–122. 17 indexed citations
15.
Ritland, S, E. Steinnes, & Sverre Skrede. (1977). Hepatic Copper Content, Urinary Copper Excretion, and Serum Ceruloplasmin in Liver Disease. Scandinavian Journal of Gastroenterology. 12(1). 81–88. 37 indexed citations
16.
Ritland, S, et al.. (1977). The electrophoretic mobility of lipoprotein x in postheparin plasma. Clinica Chimica Acta. 75(1). 129–135. 4 indexed citations
17.
Ritland, S. (1975). The Abnormal ‘Lipoprotein of Cholestasis’, Lipoprotein-X. Scandinavian Journal of Gastroenterology. 10(8). 785–789. 9 indexed citations
18.
Ritland, S, J. P. Blomhoff, & E Gjone. (1973). Lecithin.cholesterol acyl-transferase and lipoprotein-X in liver disease. Clinica Chimica Acta. 49(2). 251–259. 42 indexed citations
19.
Ritland, S, J. P. Blomhoff, K. Elgjo, & E Gjone. (1973). Lipoprotein-X (LP-X) in Liver Disease. Scandinavian Journal of Gastroenterology. 8(2). 155–160. 35 indexed citations
20.
Berg, K. J. & S Ritland. (1967). The Long‐term Prognosis of Acute Glomerulonephritis: A Follow‐up Study. Acta Medica Scandinavica. 181(1). 13–19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026